RIMCAZOLE Drug Record

  • RIMCAZOLE chembl:CHEMBL275707 Antineoplastic

    Alternate Names:

    RIMCAZOLE

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • RIMCAZOLE   SIGMAR1

    Interaction Score: 1.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name rimcazole
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • RIMCAZOLE   TP53

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • RIMCAZOLE   CYP2C9

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • RIMCAZOLE   CYP2C19

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • RIMCAZOLE   CYP1A2

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • RIMCAZOLE   CYP3A4

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TdgClinicalTrial: RIMCAZOLE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • DTC: RIMCAZOLE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL275707 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL275707

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: